Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System

Key Points. Combination of ISS and the EMC92 gene classifier is a novel clinically applicable risk classification for survival in multiple myeloma.ISS has clea

Saved in:

Bibliographic Details
Main Authors:	Kuiper, Rowan (Author) , van Duin, Mark (Author) , van Vliet, Martin H. (Author) , Broijl, Annemiek (Author) , van der Holt, Bronno (Author) , el Jarari, Laila (Author) , van Beers, Erik H. (Author) , Mulligan, George (Author) , Avet-Loiseau, Hervé (Author) , Gregory, Walter M. (Author) , Morgan, Gareth (Author) , Goldschmidt, Hartmut (Author) , Lokhorst, Henk M. (Author) , Sonneveld, Pieter (Author)
Format:	Article (Journal)
Language:	English
Published:	March 23, 2015
In:	Blood Year: 2015, Volume: 126, Issue: 17, Pages: 1996-2004
ISSN:	1528-0020
DOI:	10.1182/blood-2015-05-644039
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2015-05-644039 Verlag, lizenzpflichtig, Volltext: https://ashpublications.org/blood/article/126/17/1996/34446/Prediction-of-high-and-low-risk-multiple-myeloma
Author Notes:	Rowan Kuiper, Mark van Duin, Martin H. van Vliet, Annemiek Broijl, Bronno van der Holt, Laila el Jarari, Erik H. van Beers, George Mulligan, Hervé Avet-Loiseau, Walter M. Gregory, Gareth Morgan, Hartmut Goldschmidt, Henk M. Lokhorst, and Pieter Sonneveld

Description
Summary:	Key Points. Combination of ISS and the EMC92 gene classifier is a novel clinically applicable risk classification for survival in multiple myeloma.ISS has clea
Item Description:	Gesehen am 02.06.2020
Physical Description:	Online Resource
ISSN:	1528-0020
DOI:	10.1182/blood-2015-05-644039